Gilead Sciences, Inc.
CH ˙ SWX ˙ US3755581036
SecurityCH:GILD / Gilead Sciences, Inc.
InstitutionKimelman & Baird, LLC
Latest Disclosed Ownership200 shares
Latest Disclosed Value $ 27,874
Kimelman & Baird, LLC ownership in GILD / Gilead Sciences, Inc.

On May 13, 2026 - Kimelman & Baird, LLC filed a 13F-HR form disclosing ownership of 200 shares of Gilead Sciences, Inc. (CH:GILD) valued at $27,874 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 6, 2026 disclosing 200 shares of Gilead Sciences, Inc.. This represents a change in shares of 0.00% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-13 2026-03-31 13F GILEAD SCIENCES COM 375558103 200 0 0.00 28 12.50 0.0023
2026-02-06 2025-12-31 13F GILEAD SCIENCES COM 375558103 200 0 0.00 25 9.09 0.0019
2025-11-25 2025-09-30 13F GILEAD SCIENCES COM 375558103 200 0 0.00 22 0.00 0.0017
2025-08-12 2025-06-30 13F GILEAD SCIENCES COM 375558103 200 0 0.00 22 0.00 0.0018
2025-05-13 2025-03-31 13F GILEAD SCIENCES COM 375558103 200 0 0.00 22 22.22 0.0019
2025-02-10 2024-12-31 13F GILEAD SCIENCES COM 375558103 200 0 0.00 18 12.50 0.0015
2024-11-15 2024-09-30 13F GILEAD SCIENCES COM 375558103 200 0 0.00 17 23.08 0.0013
2024-08-19 2024-06-30 13F GILEAD SCIENCES COM 375558103 200 200 14 0.0011
2018-03-06 2017-12-31 13F Gilead Sciences cs 375558103 0 -2,550 -100.00 0 -100.00
2018-01-02 2017-09-30 13F Gilead Sciences cs 375558103 2,550 2,550 207 0.0309
2017-04-10 2016-12-31 13F Gilead Sciences COM 375558103 0 -2,550 -100.00 0 -100.00
2016-12-13 2016-09-30 13F Gilead Sciences COM 375558103 2,550 0 0.00 202 -5.16 0.0355
2016-08-16 2016-06-30 13F Gilead Sciences COM 375558103 2,550 50 2.00 213 -7.39 0.0389
2016-05-13 2016-03-31 13F Gilead Sciences COM 375558103 2,500 -17 -0.68 230 -9.80 0.0430
2016-02-12 2015-12-31 13F Gilead Sciences COM 375558103 2,517 17 0.68 255 -12.97 0.0480
2015-08-12 2015-06-30 13F Gilead Sciences cs 375558103 2,500 0 0.00 293 19.59 0.0500
2015-05-12 2015-03-31 13F Gilead Sciences cs 375558103 2,500 0 0.00 245 3.81 0.0447
2015-02-12 2014-12-31 13F Gilead Sciences cs 375558103 2,500 0 0.00 236 -11.28 0.0425
2014-11-13 2014-09-30 13F Gilead Sciences COM 375558103 2,500 0 0.00 266 28.50 0.0503
2014-08-14 2014-06-30 13F Gilead Sciences cs 375558103 2,500 2,500 207 0.0364
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.